Cray C, Levy R B
Department of Microbiology and Immunology, University of Miami School of Medicine, Florida 33101.
Transplantation. 1989 Dec;48(6):1057-63. doi: 10.1097/00007890-198912000-00033.
The present studies were undertaken to examine the ability of a viral pathogen to enhance immune alterations associated with parent----F1 graft-versus-host reactions (GvHR) across defined donor/recipient MHC genetic disparities. Murine cytomegalovirus (MCMV) was administered concurrently with a parental lymphoid inoculum into unirradiated F1 recipients in strain combinations limiting allogeneic differences to the entire MHC complex (class I/II), the H-2K region (class I), or H-2IA (class II) regions only. Alterations previously found to be associated with GvHR involving changes in the expression of Ly-6, Lyt-2, and L3T4 were examined to characterize the effects of MCMV. Mice receiving low numbers of class I/II-disparate parental cells or MCMV alone failed to exhibit significant GvHR-associated changes. In contrast, introduction of cells and virus resulted in marked alterations characteristic of F1 recipients injected with a large parental cell inoculum alone. Concurrent virus and parental cells could also induce marked changes when administered across differences involving only a class I-disparate--but not class II-disparate only--P----F1 combination. In addition to the phenotypic changes observed during the concurrent virus and class I GvHR, markedly reduced spleen cell proliferative activity and associated weight loss and mortality appeared to indicate that virus had enhanced this reaction. In total, these findings demonstrated that a donor/recipient class I MHC difference was necessary for virus and parental cells to induce the changes observed, and thus not all donor/recipient antigenic differences will result in a similar virus-induced effect. The results are discussed with respect to the potential mechanisms that may account for the apparent exacerbation of GvHR-associated alterations.
本研究旨在检验一种病毒病原体增强与亲代-F1移植物抗宿主反应(GvHR)相关的免疫改变的能力,该反应跨越特定的供体/受体MHC基因差异。将鼠巨细胞病毒(MCMV)与亲代淋巴细胞接种物同时给予未受照射的F1受体,采用的品系组合将同种异体差异限制在整个MHC复合体(I/II类)、H-2K区域(I类)或仅H-2IA(II类)区域。研究了先前发现与GvHR相关的涉及Ly-6、Lyt-2和L3T4表达变化的改变,以表征MCMV的作用。接受少量I/II类不同亲代细胞或单独接受MCMV的小鼠未表现出明显的与GvHR相关的变化。相比之下,引入细胞和病毒导致了仅注射大量亲代细胞接种物的F1受体所特有的明显改变。当仅涉及I类不同(而非仅II类不同)的亲代-F1组合给予病毒和亲代细胞时,也可诱导明显变化。除了在病毒与I类GvHR同时发生期间观察到的表型变化外,脾细胞增殖活性明显降低以及相关的体重减轻和死亡率似乎表明病毒增强了这种反应。总的来说,这些发现表明供体/受体I类MHC差异是病毒和亲代细胞诱导所观察到的变化所必需的,因此并非所有供体/受体抗原差异都会导致类似的病毒诱导效应。讨论了可能解释GvHR相关改变明显加重的潜在机制。